Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

This study has been completed.

Study NCT00586651 Information provided by Cephalon

First Received: December 21, 2007 Last Updated: August 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2010
Primary Completion Date:	October 2009 (Final data collection date for primary outcome measure)